| Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium A Venkatesan, AR Tunkel, KC Bloch, AS Lauring, J Sejvar, A Bitnun, ... Clinical Infectious Diseases 57 (8), 1114-1128, 2013 | 1198 | 2013 |
| Quasispecies theory and the behavior of RNA viruses AS Lauring, R Andino PLoS pathogens 6 (7), e1001005, 2010 | 1077 | 2010 |
| Genetic variants of SARS-CoV-2—what do they mean? AS Lauring, EB Hodcroft Jama 325 (6), 529-531, 2021 | 783 | 2021 |
| Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants Q Wang, S Iketani, Z Li, L Liu, Y Guo, Y Huang, AD Bowen, M Liu, ... Cell 186 (2), 279-286. e8, 2023 | 758 | 2023 |
| Association between mRNA vaccination and COVID-19 hospitalization and disease severity MW Tenforde, WH Self, K Adams, M Gaglani, AA Ginde, T McNeal, ... Jama 326 (20), 2043-2054, 2021 | 685 | 2021 |
| Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study AS Lauring, MW Tenforde, JD Chappell, M Gaglani, AA Ginde, T McNeal, ... bmj 376, 2022 | 632 | 2022 |
| Tocilizumab for treatment of mechanically ventilated patients with COVID-19 EC Somers, GA Eschenauer, JP Troost, JL Golob, TN Gandhi, L Wang, ... Clinical Infectious Diseases 73 (2), e445-e454, 2021 | 547 | 2021 |
| Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising … WH Self MMWR. Morbidity and mortality weekly report 70, 2021 | 517 | 2021 |
| Complexities of viral mutation rates KM Peck, AS Lauring Journal of virology 92 (14), 10.1128/jvi. 01031-17, 2018 | 490 | 2018 |
| The role of mutational robustness in RNA virus evolution AS Lauring, J Frydman, R Andino Nature Reviews Microbiology 11 (5), 327-336, 2013 | 434 | 2013 |
| Rationalizing the development of live attenuated virus vaccines AS Lauring, JO Jones, R Andino Nature biotechnology 28 (6), 573-579, 2010 | 372 | 2010 |
| Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient JH Baang, C Smith, C Mirabelli, AL Valesano, DM Manthei, MA Bachman, ... The Journal of infectious diseases 223 (1), 23-27, 2021 | 331 | 2021 |
| Sustained effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 associated hospitalizations among adults—United States, March–July 2021 MW Tenforde MMWR. Morbidity and mortality weekly report 70, 2021 | 264 | 2021 |
| Stochastic processes constrain the within and between host evolution of influenza virus JT McCrone, RJ Woods, ET Martin, RE Malosh, AS Monto, AS Lauring Elife 7, e35962, 2018 | 212 | 2018 |
| Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking H Wang, JW Perry, AS Lauring, P Neddermann, R De Francesco, AW Tai Gastroenterology 146 (5), 1373-1385. e11, 2014 | 192 | 2014 |
| Effectiveness of mRNA vaccination in preventing COVID-19–associated invasive mechanical ventilation and death—United States, March 2021–January 2022 MW Tenforde MMWR. Morbidity and mortality weekly report 71, 2022 | 186 | 2022 |
| Identification of a cellular cofactor required for infection by feline leukemia virus MM Anderson, AS Lauring, CC Burns, J Overbaugh Science 287 (5459), 1828-1830, 2000 | 162 | 2000 |
| Effectiveness of SARS-CoV-2 mRNA vaccines for preventing Covid-19 hospitalizations in the United States MW Tenforde, MM Patel, AA Ginde, DJ Douin, HK Talbot, JD Casey, ... MedRxiv, 2021 | 161 | 2021 |
| Codon usage determines the mutational robustness, evolutionary capacity, and virulence of an RNA virus AS Lauring, A Acevedo, SB Cooper, R Andino Cell host & microbe 12 (5), 623-632, 2012 | 159 | 2012 |
| A novel twelve class fluctuation test reveals higher than expected mutation rates for influenza A viruses MD Pauly, MC Procario, AS Lauring Elife 6, e26437, 2017 | 155 | 2017 |